Clinical Trial Update: Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating weekly vs. twice-weekly intralesional Glucantime injections for anthroponotic cutaneous leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Glucantime (meglumine antimoniate)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Cutaneous Leishmaniasis | Phase 3 | Status: COMPLETED